<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia</id>
	<title>Ventricular Fibrillation Pulseless Ventricular Tachycardia - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;action=history"/>
	<updated>2026-08-18T10:04:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=27720&amp;oldid=prev</id>
		<title>Mfrdmanager at 13:40, 13 November 2020</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=27720&amp;oldid=prev"/>
		<updated>2020-11-13T13:40:50Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:40, 13 November 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l40&quot; &gt;Line 40:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not interrupt compressions to place an advanced airway&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not interrupt compressions to place an advanced airway&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Adrenergics&lt;/del&gt;|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Epinephrine&lt;/ins&gt;|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;:'''OR'''&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;* Administer [[Vasopressin|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;** Vasopressin is a one-time dose&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not stop CPR to administer medications&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not stop CPR to administer medications&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Reassess for circulation every two minutes&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Reassess for circulation every two minutes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l47&quot; &gt;Line 47:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 50:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic.  If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j.  (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic.  If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j.  (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer antidysrhythmic medication:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer antidysrhythmic medication:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;** [[Amiodarone|AMIODARONE]] 300 mg IVP, IO.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;** May repeat second dose [[Amiodarone|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|LIDOCAINE]] DRIP 1-4 mg/min.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;*** Maximum dose 450 mg.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;:'''OR'''&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Lidocaine&lt;/ins&gt;|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Lidocaine&lt;/ins&gt;|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Lidocaine&lt;/ins&gt;|LIDOCAINE]] DRIP 1-4 mg/min.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Lidocaine&lt;/ins&gt;|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Magnesium Sulfate&lt;/ins&gt;|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Sodium Bicarbonate&lt;/ins&gt;|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''If patient combative post resuscitation, refer to [[Analgesia and Sedation|ANALGESIA / SEDATION PARAMETER (2.04)]]'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''If patient combative post resuscitation, refer to [[Analgesia and Sedation|ANALGESIA / SEDATION PARAMETER (2.04)]]'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=16040&amp;oldid=prev</id>
		<title>Mfrdmanager: /* When the Patient found in cardiac arrest: */</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=16040&amp;oldid=prev"/>
		<updated>2018-03-21T21:13:09Z</updated>

		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;When the Patient found in cardiac arrest:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 21:13, 21 March 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l47&quot; &gt;Line 47:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 47:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic.  If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j.  (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic.  If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j.  (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer antidysrhythmic medication:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer antidysrhythmic medication:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;** [[Antiarrhythmics|AMIODARONE]] 300 mg IVP, IO.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;** May repeat second dose [[Antiarrhythmics|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;*** Maximum dose 450 mg.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;:'''OR'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[Antiarrhythmics|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[Antiarrhythmics|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=16039&amp;oldid=prev</id>
		<title>Mfrdmanager: /* When the Patient found in cardiac arrest: */</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=16039&amp;oldid=prev"/>
		<updated>2018-03-21T21:12:35Z</updated>

		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;When the Patient found in cardiac arrest:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 21:12, 21 March 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l41&quot; &gt;Line 41:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 41:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[Adrenergics|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Administer [[Adrenergics|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;:'''OR'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;* Administer [[Hormones Vitamins|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;** Vasopressin is a one-time dose&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not stop CPR to administer medications&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Do not stop CPR to administer medications&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Reassess for circulation every two minutes&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Reassess for circulation every two minutes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=115&amp;oldid=prev</id>
		<title>Mfrdmanager: Protected &quot;Ventricular Fibrillation Pulseless Ventricular Tachycardia&quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=115&amp;oldid=prev"/>
		<updated>2018-02-10T14:04:47Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&quot; title=&quot;Ventricular Fibrillation Pulseless Ventricular Tachycardia&quot;&gt;Ventricular Fibrillation Pulseless Ventricular Tachycardia&lt;/a&gt;&amp;quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:04, 10 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=114&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;==Section 4 - CARDIAC== ===4.08 CARDIAC ARREST - VENTRICULAR FIBRILLATION /PULSELESS VENTRICULAR TACHYCARDIA===   Ventricular Fibrillation (VF) and Pulseless V-Tach (VT) focus...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Ventricular_Fibrillation_Pulseless_Ventricular_Tachycardia&amp;diff=114&amp;oldid=prev"/>
		<updated>2018-02-10T14:04:39Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 4 - CARDIAC== ===4.08 CARDIAC ARREST - VENTRICULAR FIBRILLATION /PULSELESS VENTRICULAR TACHYCARDIA===   Ventricular Fibrillation (VF) and Pulseless V-Tach (VT) focus...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 4 - CARDIAC==&lt;br /&gt;
===4.08 CARDIAC ARREST - VENTRICULAR FIBRILLATION /PULSELESS VENTRICULAR TACHYCARDIA===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Ventricular Fibrillation (VF) and Pulseless V-Tach (VT) focuses in the correction of the dysrhythmia into a pulse producing rhythm. Consider all possible reversible causes for cardiac arrest utilizing a national recommended mnemonic of “H’s and T’s”:&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! H’s !! T’s&lt;br /&gt;
|-&lt;br /&gt;
| Hypovolemia|| Tension Pneumothorax&lt;br /&gt;
|-&lt;br /&gt;
| Hypoxia|| Tamponade, cardiac&lt;br /&gt;
|-&lt;br /&gt;
| Hydrogen Ion (acidosis)|| Toxins or Tablets (overdose)&lt;br /&gt;
|-&lt;br /&gt;
| Hypo/hyperkalemia|| Thrombosis, pulmonary&lt;br /&gt;
|-&lt;br /&gt;
| Hypothermia|| Thrombosis, cardiac&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
In addition, also consider the following:&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| Hypoglycemia|| Trauma&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====When the Patient found in cardiac arrest:====&lt;br /&gt;
* Initiate BLS algorhythm with 5 cycles of high quality CPR (push hard/push fast)&lt;br /&gt;
** Minimum of 100 compressions per minute, minimize interruptions&lt;br /&gt;
** Compression rate of 30:2 for approximately 2 minutes&lt;br /&gt;
** Depth of compression of at least 2 inches&lt;br /&gt;
** Initiate the use of a mechanical compression device if available&lt;br /&gt;
* Assist ventilations with OXYGEN @ 100% via BVM - DO NOT HYPERVENTILATE&lt;br /&gt;
* Attach cardiac monitor – Evaluate the cardiac rhythm&lt;br /&gt;
** VF/VT Present – deliver a DEFIBRILLATION 120-200j biphasic&lt;br /&gt;
* Continue high quality CPR/Ventilations for 2 minutes&lt;br /&gt;
* Establish intravenous access via IV or IO&lt;br /&gt;
* Consider advanced airway procedure using supraglottic airway (king tube) or endotracheal intubation&lt;br /&gt;
** Do not interrupt compressions to place an advanced airway&lt;br /&gt;
** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;br /&gt;
* Administer [[Adrenergics|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;br /&gt;
:'''OR'''&lt;br /&gt;
* Administer [[Hormones Vitamins|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine&lt;br /&gt;
** Vasopressin is a one-time dose&lt;br /&gt;
** Do not stop CPR to administer medications&lt;br /&gt;
* Reassess for circulation every two minutes&lt;br /&gt;
** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic&lt;br /&gt;
** Subsequent shocks should be at the higher dose selected&lt;br /&gt;
''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic.  If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j.  (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])&lt;br /&gt;
* Administer antidysrhythmic medication:&lt;br /&gt;
** [[Antiarrhythmics|AMIODARONE]] 300 mg IVP, IO.&lt;br /&gt;
** May repeat second dose [[Antiarrhythmics|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.&lt;br /&gt;
*** Maximum dose 450 mg.&lt;br /&gt;
:'''OR'''&lt;br /&gt;
* Administer [[Antiarrhythmics|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.&lt;br /&gt;
** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.&lt;br /&gt;
** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Antiarrhythmics|LIDOCAINE]] DRIP 1-4 mg/min.&lt;br /&gt;
** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.&lt;br /&gt;
* Administer [[Electrolytes|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)&lt;br /&gt;
* Administer [[Electrolytes|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD&lt;br /&gt;
&lt;br /&gt;
'''If patient combative post resuscitation, refer to [[Analgesia and Sedation|ANALGESIA / SEDATION PARAMETER (2.04)]]'''&lt;br /&gt;
&lt;br /&gt;
'''''Deliver all Defibrillations at 360 Joules in any patient who has had an Automatic Implanted Cardioverter Defibrillator (AICD) shock. (Use Anterior/Posterior position if possible for Defibrillator Pads - Do not place pads over device).'''''&lt;br /&gt;
*Consider sedation in patient experiencing cardioversion or defibrillation by their own AICD.&lt;br /&gt;
* Leave copy of ECG at ER on any patient with implanted device.&lt;br /&gt;
&lt;br /&gt;
[[File:Adult_Cardiac_Arrest_Flowchart.jpg|500px]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Cardiac|0408]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>